You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINETM molecule that releases fully potent IL-2 in the tumor microenvironment

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINETM molecule that releases fully potent IL-2 in the tumor microenvironment

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023156016
Dec 202332010
Jan 20241502
Feb 20243204
Mar 202422018
Apr 20241403
May 20243003
Jun 20243008
Jul 20247803
Aug 20242404
Sep 20241802
Oct 20241805
Nov 20243205
Dec 202450013
Jan 20252805
Feb 2025307
Mar 2025006
Apr 2025004
May 20250010
Jun 2025203
Total5840131